Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Overweight men spend more on prescription drugs than normal-weight men

08.11.2004


As middle-aged men’s weight goes up, so do their monthly costs for prescription drugs to treat heart disease risk factors and weight-related conditions, according to research presented at the American Heart Association’s Scientific Sessions 2004. In a study of 328 men who participated in a health screening, normal-weight men spent an average of $22.84 per month at the pharmacy. Overweight men averaged $39.27 per month, and obese men spent $80.31 per month – about 3.5 times what their normal-weight counterparts spent.



"These are what we call ’real and immediate costs.’ These are not the costs associated with an operation or serious event like a heart attack that might happen at some time in the future. Rather, this is what the men, or their employers, spend month after month on their prescription drugs," said Thomas G. Allison, Ph.D., M.P.H., lead author of the study and a consultant in internal medicine and cardiovascular disease at the Mayo Clinic in Rochester, Minn.

The researchers studied male business executives, average age 47, who had been sent by their companies to have physical examinations at Mayo Clinic’s Executive Physical program between January 2001 and May 2002. The men, who did not have heart disease and were first-time participants in the program, had a cardiovascular risk factor evaluation as part of their exams.


Allison and his colleagues tallied the cost of drugs prescribed to the men as a result of their examinations. The tally also included the cost of prescriptions for drugs they were already taking. Allison said that while he and colleagues had embarked on a study looking at something related to obesity, they were somewhat surprised at the health problems associated with the condition. "We did not expect to see such significant health problems so strongly associated with weight, including degenerative joint disease, depression, sleep apnea, high blood pressure, high blood cholesterol and more," Allison said. "We began to think, ’How could we quantify it?’" One way to summarize the impact, the researchers concluded, was to figure out how much people in different weight categories spent each month at the pharmacy.

The researchers divided the subjects into weight categories: normal-weight men had a body mass index (BMI) of less than 25; overweight men had a BMI of 25 to 30; and obese men had a BMI higher than 30. Fifteen percent of the men studied were normal weight, 52 percent were overweight, and 32 percent were obese. Pharmacy costs were subdivided into drugs prescribed to treat coronary heart disease (CHD) risk factors and those for other medical conditions related to weight.

For normal-weight men, prescriptions for CHD risk factors cost $9.89 per month, and those for other medical conditions cost $12.96 per month. For overweight men, CHD-related prescriptions cost $18.41 per month and other prescriptions $20.86. For obese men, CHD-related drugs cost $42.02 per month and other drugs were $38.29.

All major CHD risk factors except smoking increased as BMI class increased. The prevalence of low back pain/degenerative joint disease, erectile dysfunction, sleep apnea, gastroesophageal reflux, depression and gout increased as BMI increased. "Previous studies looking at the cost of obesity might be underestimating the toll," Allison said. "The men in this study were in a health program that exceeds the type of physical examination that a normal healthcare plan would offer."

Allison also said that companies should take notice of these costs and, perhaps, invest in programs to reduce obesity in the workplace. Co-authors are Iftikhar J. Kullo, M.D; Chul Kim, M.D.; and Donald D. Hensrud, M.D.

Maggie Francis | EurekAlert!
Further information:
http://www.heart.org

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>